Sestak I, Regan M, Dodson A, et al. Integration of clinical variables for the prediction of late distant recurrence in patients with oestrogen receptor positive breast cancer treated with 5 years of endocrine therapy. SABCS 2017, GS6-01.
Beïnvloedt overgewicht het veiligheidsprofiel van nivolumab?
mrt 2023 | Dermato-oncologie, Hoofd-halsoncologie, Immuuntherapie, Longoncologie, Lymfoom, Maag-darm-leveroncologie, Uro-oncologie